Global pharma giant recently announced that its drug candidate for cancer- the combination of Tecentriq (atezolizumab) p...
Singapore – Scientists and clinicians from Singapore institutes are collaborating with C&C Research ...
LUMICKS, a world leader in dynamic single-molecule analysis, has partnered with AstraZeneca and the University of Cambri...
Ascletis BioScience Co., Ltd. and CR Pharmaceutical Commercial Group Co., Ltd. have jointly announced that the two parti...
Singapore - AUM Biosciences (AUM), a new company focused on the development of innovative and affordable oncology m...
Global pharmaceutical company Mylan has announced the US launch of Bivalirudin for Injection, 250 mg singl...
Ascletis (partner of WuXi STA) receives approval from National Drug Administration of China (CNDA, former CFDA) of its C...
Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of d...
Singapore- TESARO, an oncology-focused biopharmaceutical company, announced that it has entered into a clinical co...
Japan’s Astellas Pharma recently announced that the U.S. Food and Drug Administration (FDA) has accepted, with Pri...
Singapore- Versartis and Aravive Biologics jointly announced that they have entered into a definitive agreement under wh...
Singapore- Blueprint Medicines and CStone Pharmaceuticals, a privately-held biopharmaceutical company announce an e...
Singapore- Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) has a...
Singapore- Amgen, in a two-sentence announcement, said it received a complete response letter for the biosimilar of Roch...
Global drug giant, Roche recently announced that the European Commission has approved Perjeta (pertuzumab) in combinatio...
LUYE PHARMA announced that the Group entered into a collaboration and license agreement with Elpis Biopharm, a Boston-re...
Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...
Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...
